NOVACARE: what changed
NOVACARE
Largest movements
- Cash +€7,260
up €7,260 (+60.0%), from €12,101 to €19,362
mainly Net result for the year (+€5,299) and Short-term financial debts (+€2,244)
- Receivables within one year +€1,465
up €1,465 (+6.0%), from €24,292 to €25,757
of which Other amounts receivable: +€1,215
- Profit (loss) carried forward +€5,154
no longer reported in 2025 (was -€5,154)
- Short-term financial debts +€2,244
up €2,244 (+24.7%), from €9,083 to €11,326
- Tax, wage and social debts +€1,681
up €1,681 (+342%), from €492 to €2,172
- Trade debts -€545
down €545 (-36.7%), from €1,483 to €939
- Gross operating margin +€6,822
up €6,822, from -€1,076 to €5,746
- Depreciation -€642
no longer reported in 2025 (was €642)
- Taxes +€165
new in 2025: €165
- Other operating charges +€165
up €165 (+22.1%), from €746 to €910
- Financial charges +€83
up €83 (+16.5%), from €503 to €585
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,444 | €45,170 | +€8,727 | +23.9% |
| Current assets | 29/58 | €36,444 | €45,170 | +€8,727 | +23.9% |
| Amounts receivable within one year | 40/41 | €24,292 | €25,757 | +€1,465 | +6.0% |
| Trade receivables | 40 | - | €250 | +€250 | |
| Other amounts receivable | 41 | €24,292 | €25,507 | +€1,215 | +5.0% |
| Cash at bank and in hand | 54/58 | €12,101 | €19,362 | +€7,260 | +60.0% |
| Deferred charges and accrued income | 490/1 | €50 | €52 | +€2 | +3.5% |
| Total equity and liabilities | 10/49 | €36,444 | €45,170 | +€8,727 | +23.9% |
| Equity | 10/15 | €24,522 | €29,821 | +€5,299 | +21.6% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €17,276 | €17,421 | +€145 | +0.8% |
| Distributable reserves | 133 | €17,276 | €17,421 | +€145 | +0.8% |
| Profit (loss) carried forward | 14 | -€5,154 | - | +€5,154 | |
| Amounts payable | 17/49 | €11,922 | €15,349 | +€3,427 | +28.7% |
| Amounts payable within one year | 42/48 | €11,922 | €15,349 | +€3,427 | +28.7% |
| Financial debts | 43 | €9,083 | €11,326 | +€2,244 | +24.7% |
| Other loans | 439 | €9,083 | €11,326 | +€2,244 | +24.7% |
| Trade debts | 44 | €1,483 | €939 | -€545 | -36.7% |
| Suppliers | 440/4 | €1,483 | €939 | -€545 | -36.7% |
| Taxes, remuneration and social security | 45 | €492 | €2,172 | +€1,681 | +342% |
| Taxes | 450/3 | €492 | €2,172 | +€1,681 | +342% |
| Other amounts payable | 47/48 | €864 | €912 | +€48 | +5.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €642 | - | -€642 | |
| Other operating charges | 640/8 | €746 | €910 | +€165 | +22.1% |
| Gross operating margin | 9900 | -€1,076 | €5,746 | +€6,822 | |
| Operating profit (loss) | 9901 | -€2,464 | €4,835 | +€7,299 | |
| Financial income | 75/76B | €1,160 | €1,215 | +€55 | +4.7% |
| Recurring financial income | 75 | €1,160 | €1,215 | +€55 | +4.7% |
| Financial charges | 65/66B | €503 | €585 | +€83 | +16.5% |
| Recurring financial charges | 65 | €503 | €585 | +€83 | +16.5% |
| Profit (loss) for the period before taxes | 9903 | -€1,806 | €5,465 | +€7,271 | |
| Income taxes | 67/77 | - | €165 | +€165 | |
| Profit (loss) for the period | 9904 | -€1,806 | €5,299 | +€7,106 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,806 | €5,299 | +€7,106 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.